Search

Your search keyword '"Biological products industry -- Officials and employees"' showing total 7,776 results
Start Over Descriptor "Biological products industry -- Officials and employees"
7,776 results on '"Biological products industry -- Officials and employees"'

1. PERSISTENT PAYOFF: Raleigh investor Himanshu Shah outperforms the market by targeting complacent management

Author

Roush, Chris

Subjects
Sanofi S.A. -- Officials and employees, Biological products industry -- Officials and employees, Hedge funds, Type 2 diabetes, Pharmaceutical industry -- Officials and employees, Business, Business, regional
Abstract

Himanshu Shah has been running Raleigh's Shah Capital Management for nearly two decades, attributing his success to persistence--and he's got the numbers to prove it. Started in 2005, his hedge [...]

Published
2024

2. BIOPOWER PLAYER: Arie Belldegrun is determined to make L.A. a heavy hitter in the biotech ecosphere.

Author

Fine, Howard

Subjects
Biological products industry -- Officials and employees, Biological products, Biotechnology, Biomass energy, Entrepreneurship, New business enterprises, Businesspeople, Concerts -- Concert reviews
Abstract

When biotech entrepreneur Keith Leonard took the stage as the keynote speaker at a recent conference celebrating successes along the 101 Biotech Corridor in western L.A. County and eastern Ventura [...]

Published
2024

3. Biogen appoints Quirk as Chief Medical Officer

Subjects
Bristol-Myers Squibb Co. -- Officials and employees, Biological products industry -- Officials and employees, Business, News, opinion and commentary
Abstract

Biogen (BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as Chief Medical Officer and Head of Medical Affairs, effective October 28, 2024. Dr. Quirk will report to Priya Singhal, M.D., [...]

Published
2024

4. Cosciens Biopharma director Carolyn Egbert resigns

Subjects
Biological products industry -- Officials and employees, Corporate directors -- Appointments, resignations and dismissals, Business, News, opinion and commentary
Abstract

COSCIENS Biopharma announced the resignation of Carolyn Egbert from the Board of Directors, effective immediately. 'We are extremely grateful to Carolyn for her twelve years of dedicated service to the [...]

Published
2024

5. Neogen appoints Bernard to the board of directors

Subjects
QIAGEN N.V. -- Officials and employees, Neogen Corp. -- Officials and employees, Biological products industry -- Officials and employees, Horticultural industry -- Officials and employees, Boards of directors -- Appointments, resignations and dismissals, Business, News, opinion and commentary
Abstract

Neogen Corporation (NEOG) announced that it has appointed Thierry Bernard as a director to its Board, effective November 1, 2024. Thierry Bernard is Chief Executive Officer of QIAGEN N.V. [...]

Published
2024

6. Biogen appoints Minor, Pangalos as new independent directors

Subjects
AstraZeneca PLC -- Officials and employees, Biological products industry -- Officials and employees, Executives -- Appointments, resignations and dismissals, Pharmaceutical industry -- Officials and employees, Business, News, opinion and commentary
Abstract

The Biogen Board of Directors announced the appointments of two new independent directors, Lloyd B. Minor, M.D., effective October 1, 2024, and Sir Menela Pangalos, Ph.D., effective January 1, 2025. [...]

Published
2024

7. Tanvex BioPharma appoints Stephen Lam as chief executive officer

Subjects
Biological products industry -- Officials and employees, Chief executive officers -- Appointments, resignations and dismissals, Pharmaceuticals and cosmetics industries
Abstract

Tanvex BioPharma, Inc.,a biosimilar-focused biopharmaceutical company and CDMO, announced that its board of directors has appointed Stephen Lam as the company's chief executive officer, effective September 5, 2024. Stephen succeeds [...]

Published
2024

8. Trump Taps Vaccine Skeptic RFK JR. For Health Secretary; CNN Inside Brutal Prison; Russian TV Celebrates Gabbard. Aired 7-8p ET

Subjects
United States. Senate -- Officials and employees, Cable News Network -- Officials and employees, Biological products industry -- Officials and employees, Governmental investigations, Prisons, Vaccines, General interest, News, opinion and commentary
Abstract

[19:00:34] ERIN BURNETT, CNN HOST: OUTFRONT next: The breaking news, vaccine makers shares tumbling after Trump announces RFK Jr. will be his top health official. Kennedy vowing to make America [...]

Published
2024

9. Q3 2024 Xbrane Biopharma AB Earnings Call - Final

Subjects
Biological products industry -- Officials and employees, Business
Abstract

Presentation MARTIN AMARK, CHIEF EXECUTIVE OFFICER, XBRANE BIOPHARMA AB: Hello, everybody, and welcome to this webcast in relation to our quarterly report, the third quarter of 2024, Xbrane Biopharma. I [...]

Published
2024

10. SpyBiotech Names Dr. Prakash Bhuyan as Chief Medical Officer

Subjects
AstraZeneca PLC -- Officials and employees, Biological products industry -- Officials and employees, Communicable diseases, Chronic diseases, Vaccines, Pharmaceutical industry -- Officials and employees, Arts and entertainment industries
Abstract

SpyBiotech, a biotechnology company with a novel vaccine platform technology that can target infectious diseases, cancer, and chronic diseases, has appointed Dr. Prakash Bhuyan as Chief Medical Officer. The company [...]

Published
2024

11. CEL-SCI: Robert Watson Appointed Chairperson of the Board

Subjects
CEL-SCI Corp. -- Officials and employees, Biological products industry -- Officials and employees, Chairpersons -- Appointments, resignations and dismissals, Investment bankers -- Appointments, resignations and dismissals, Arts and entertainment industries, Multikine (Medication)
Abstract

CEL-SCI Corp. reported that Robert (Bob) Watson, who has served as a Director of the Company since 2017, has been appointed Chairperson of the Board. The company said that Watson [...]

Published
2024

12. Xeris Biopharma Highlights CEO Succession Plan

Subjects
Biological products industry -- Officials and employees, Succession planning (Business), Chairpersons -- Appointments, resignations and dismissals, Arts and entertainment industries
Abstract

Xeris Biopharma Holdings, a biopharmaceutical company committed to improving patient lives by developing and commercializing products across a range of therapies, reported a CEO succession plan effective August 1, under [...]

Published
2024

13. CEL-SCI Names Robert Watson as Chairperson of the Board

Subjects
CEL-SCI Corp. -- Officials and employees, Biological products industry -- Officials and employees, Chairpersons -- Appointments, resignations and dismissals, Investment bankers -- Appointments, resignations and dismissals, Arts and entertainment industries, Multikine (Medication)
Abstract

CEL-SCI Corp. reported that Robert (Bob) Watson, who has served as a Director of the Company since 2017, has been appointed Chairperson of the Board. The company said that Watson [...]

Published
2024

14. Sutro Biopharma appoints Leyman as Chief Business Development Officer

Subjects
Biological products industry -- Officials and employees, Business, News, opinion and commentary
Abstract

Sutro Biopharma announced the appointment of Barbara Leyman, Ph.D., as Chief Business Development Officer, effective July 8, 2024. Dr. Leyman brings 20 years of life science industry business development, investing, [...]

Published
2024

15. LimmaTech Appoints Staph Leavenworth Bakali as Chairman of the Board

Subjects
Biological products industry -- Officials and employees, Health care industry -- Officials and employees, Chairpersons -- Appointments, resignations and dismissals, Health care industry, Arts and entertainment industries
Abstract

LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, reported the appointment of Staph Leavenworth Bakali as independent Chairman of its Board of Directors. [...]

Published
2024

16. CEL-SCI appoints Robert Watson as chairperson

Subjects
Biological products industry -- Officials and employees, Chairpersons -- Appointments, resignations and dismissals, Business, News, opinion and commentary
Abstract

CEL-SCI announced that Robert Watson, who has served as a director of the company since 2017, has been appointed chairperson of the board. Watson brings expertise in capital formation strategies [...]

Published
2024

17. Xeris Biopharma CEO Paul Edick to retire, John Shannon to succeed

Subjects
Biological products industry -- Officials and employees, Succession planning (Business), Chief executive officers -- Appointments, resignations and dismissals, Chairpersons -- Appointments, resignations and dismissals, Business, News, opinion and commentary
Abstract

Xeris Biopharma announced a CEO succession plan effective August 1, under which Paul Edick will be retiring from his day-to-day operational and chairman role at Xeris after more than seven [...]

Published
2024

18. Benitec Biopharma appoints Kishen Mehta to board of directors

Subjects
Biological products industry -- Officials and employees, Boards of directors -- Appointments, resignations and dismissals, Business, News, opinion and commentary
Abstract

Benitec Biopharma announces the appointment of Kishen Mehta to the board of directors of the Company, effective June 26, 2024. Mr. Mehta's appointment follows the $40M private investment in public [...]

Published
2024

19. Connect Biopharma appoints Barry Quart CEO, Xanthopoulos appointed Chair

Subjects
Biological products industry -- Officials and employees, Chief executive officers -- Appointments, resignations and dismissals, Business, News, opinion and commentary
Abstract

Connect Biopharma Holdings Limited announced the appointments of Barry Quart, Pharm.D., as Chief Executive Officer or CEO and Director, David Szekeres as President, and Kleanthis G. Xanthopoulos, Ph.D., as the [...]

Published
2024

20. Vaxxas Appoints Leading Global Vaccine Experts as the Company Advances its Needle-Free Vaccination Technology Towards Late-Stage Clinical Trials

Subjects
Biological products industry -- Officials and employees, Vaccination, Consulting services -- Officials and employees, Business, Business, international, University of Queensland -- Officials and employees
Abstract

BRISBANE, Australia & CAMBRIDGE, Mass. -- Vaxxas, a clinical-stage biotechnology company, today announced the appointments of three globally respected vaccine experts as advisors to its product development and strategy team [...]

Published
2025

21. FORM 8-K: Matinas BioPharma Holdings, Inc. Files Current Report (Jan 24, 2025)

Subjects
Biological products industry -- Officials and employees, Securities law -- Reports, Stock-exchange -- Reports, News, opinion and commentary
Abstract

Washington: Matinas BioPharma Holdings, Inc., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Jan 24, 2025: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. [...]

Published
2025

23. Emmes Group(r) names Germaine Gross Chief Commercial Officer of Emmes(r) Biopharma

Subjects
Biological products industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

ROCKVILLE, Md: Emmes has issued the following press release: Emmes Group(r), a leading specialty tech and AI-enabled global contract research organization (CRO), today announced the appointment of Germaine Gross to [...]

Published
2025

24. FORM 8-K: ENZO BIOCHEM INC Files Current Report (Jan 16, 2025)

Subjects
Enzo Biochem Inc. -- Officials and employees, Biological products industry -- Officials and employees, Stock-exchange -- Reports, Securities industry -- Officials and employees, Securities industry, News, opinion and commentary
Abstract

Washington: ENZO BIOCHEM INC, has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Jan 16, 2025: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [...]

Published
2025

25. FORM 8-K: Sunshine Biopharma Inc. Files Current Report (Jan 15, 2025)

Subjects
Biological products industry -- Officials and employees, Securities law -- Reports, Stock-exchange -- Reports, Financial statements -- Reports, News, opinion and commentary
Abstract

Washington: Sunshine Biopharma Inc., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Jan 15, 2025: UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 [...]

Published
2025

26. FORM 8-K: BIOGEN INC. Files Current Report (Jan 15, 2025)

Subjects
Biogen Inc. -- Officials and employees, Biological products industry -- Officials and employees, Securities law -- Reports, Stock-exchange -- Reports, News, opinion and commentary
Abstract

Washington: BIOGEN INC., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Jan 15, 2025: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM [...]

Published
2025

27. FORM 8-K: ENZO BIOCHEM INC Files Current Report (Jan 15, 2025)

Subjects
Enzo Biochem Inc. -- Officials and employees, Biological products industry -- Officials and employees, Stock-exchange -- Reports, Financial statements -- Reports, Securities industry -- Officials and employees, Securities industry, News, opinion and commentary
Abstract

Washington: ENZO BIOCHEM INC, has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Jan 15, 2025: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [...]

Published
2025

28. FORM 8-K: ENZO BIOCHEM INC Files Current Report (Jan 14, 2025)

Subjects
New York Stock Exchange Inc. -- Officials and employees, Enzo Biochem Inc. -- Officials and employees, Biological products industry -- Officials and employees, Financial statements -- Reports, Securities industry -- Officials and employees, Securities industry, News, opinion and commentary, Securities Exchange Act
Abstract

Washington: ENZO BIOCHEM INC, has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Jan 14, 2025: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [...]

Published
2025

29. Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer

Subjects
Biological products industry -- Officials and employees, Chief operating officers -- Appointments, resignations and dismissals, Pharmaceutical industry -- Officials and employees, Robotics, Business, Business, international
Abstract

Previously at MeiraGTx, GSK and Novartis, Dr. Leighton will help Chemify scale the company's operational capacity to meet demand for the design and synthesis of complex small molecules. GLASGOW, Scotland [...]

Published
2025

30. FORM 8-K: Cyclacel Pharmaceuticals, Inc. Files Current Report (Jan 06, 2025)

Subjects
Titan Pharmaceuticals Inc. -- Officials and employees, OpGen Inc. -- Officials and employees, The NASDAQ Stock Market L.L.C. -- Officials and employees, Biological products industry -- Officials and employees, Employers -- Reports, Securities law -- Reports, News, opinion and commentary
Abstract

Washington: Cyclacel Pharmaceuticals, Inc., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Jan 06, 2025: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [...]

Published
2025

31. Sling Therapeutics Appoints Andrew Guggenhime to its Board of Directors

Subjects
Biological products industry -- Officials and employees, Boards of directors, Business, News, opinion and commentary
Abstract

ANN ARBOR, Mich., Jan. 7, 2025 /PRNewswire/ -- Sling Therapeutics, Inc., a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease [...]

Published
2025

32. FORM 8-K: Propanc Biopharma, Inc. Files Current Report (Dec 20, 2024)

Subjects
Biological products industry -- Officials and employees, Financial statements -- Reports, News, opinion and commentary
Abstract

Washington: Propanc Biopharma, Inc., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Dec 20, 2024: UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 [...]

Published
2024

33. FORM 8-K: Cyclacel Pharmaceuticals, Inc. Files Current Report (Dec 12, 2024)

Subjects
The NASDAQ Stock Market L.L.C. -- Officials and employees, Biological products industry -- Officials and employees, Securities law -- Reports, News, opinion and commentary
Abstract

Washington: Cyclacel Pharmaceuticals, Inc., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Dec 12, 2024: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [...]

Published
2024

34. Gilead Sciences Appoints Dietmar Berger, MD, PhD, as Chief Medical Officer

Subjects
Gilead Sciences Inc. -- Officials and employees, Biological products industry -- Officials and employees, Physicians -- Appointments, resignations and dismissals, General interest, News, opinion and commentary
Abstract

FOSTER CITY: GILEAD SCIENCES, INC. has issued the following news release: Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Dietmar Berger, MD, PhD, will join the company on January 2, [...]

Published
2024

35. Gilead Sciences Appoints Dietmar Berger, MD, PhD, as Chief Medical Officer

Subjects
Gilead Sciences Inc. -- Officials and employees, Biological products industry -- Officials and employees, Trade and professional associations, Business, Business, international
Abstract

FOSTER CITY, Calif. -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical Officer and will [...]

Published
2024

36. FORM 8-K: Benitec Biopharma Inc. Files Current Report (Dec 10, 2024)

Subjects
Biological products industry -- Officials and employees, Securities law -- Reports, Stock-exchange -- Reports, Financial statements -- Reports, News, opinion and commentary
Abstract

Washington: Benitec Biopharma Inc., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Dec 10, 2024: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [...]

Published
2024

37. FORM 8-K: Propanc Biopharma, Inc. Files Current Report (Dec 06, 2024)

Subjects
Biological products industry -- Officials and employees, Financial statements -- Reports, News, opinion and commentary
Abstract

Washington: Propanc Biopharma, Inc., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Dec 06, 2024: UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 [...]

Published
2024

38. FORM 8-K: Benitec Biopharma Inc. Files Current Report (Dec 06, 2024)

Subjects
Biological products industry -- Officials and employees, Securities law -- Reports, Stock-exchange -- Reports, News, opinion and commentary
Abstract

Washington: Benitec Biopharma Inc., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Dec 06, 2024: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [...]

Published
2024

39. FORM 8-K: Zenas BioPharma, Inc. Files Current Report (Dec 02, 2024)

Subjects
Biological products industry -- Officials and employees, Securities law -- Reports, Stock-exchange -- Reports, Financial statements -- Reports, News, opinion and commentary, Securities Exchange Act
Abstract

Washington: Zenas BioPharma, Inc., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Dec 02, 2024: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [...]

Published
2024

40. Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Biological products industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

BOSTON, Mass: Cue Biopharma, Inc has issued the following news release: Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage [...]

Published
2024

42. Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharma

Author

Sorkin, Andrew Ross, Mattu, Ravi, Warner, Bernhard, Kessler, Sarah, De La Merced, Michael J., and Hirsch, Lauren

Subjects
Pfizer Inc. -- Officials and employees, Officials and employees, Vaccines, Social services, Pharmaceutical industry -- Officials and employees, Food, Biological products industry -- Officials and employees, Social service
Abstract

Donald Trump’s choice to run the Department of Health and Human Services spooked investors who worry what Kennedy would do. A billion-dollar hit to Big Pharma That didn’t take long. [...]

Published
2024

43. Lifecore Biomedical Inc Annual Shareholders Meeting - Final

Subjects
LifeCore Biomedical Inc. -- Officials and employees, Biological products industry -- Officials and employees, Chairpersons, Stockholders, Business
Abstract

Presentation PAUL JOSEPHS, PRESIDENT, CHIEF EXECUTIVE OFFICER, DIRECTOR, LIFECORE BIOMEDICAL INC: Good morning. Welcome to the 2023 Annual Meeting of Stockholders of Lifecore Biomedical, Inc. I am Paul Josephs, Lifecore's [...]

Published
2024

44. Event Brief of Biogen Inc Annual Shareholders Meeting - Final

Subjects
Biogen Inc. -- Officials and employees, Biological products industry -- Officials and employees, Stockholders, Business
Abstract

CORPORATE PARTICIPANTS . Caroline Dorsa - Biogen Inc,Chair of the Board . Wendell Taylor - Biogen Inc,Chief Corporation Counsel OVERVIEW Company Summary FINANCIAL DATA PRESENTATION Presentation 1. The fifth proposal [...]

Published
2024

45. Biogen Inc Annual Shareholders Meeting - Final

Subjects
Biogen Inc. -- Officials and employees, PricewaterhouseCoopers L.L.P. (New York, New York) -- Officials and employees, Biological products industry -- Officials and employees, Accounting firms -- Officials and employees, Stockholders, Business
Abstract

Presentation OPERATOR: Welcome to the Annual Meeting for Biogen Inc. Our host for today's call is Caroline Dorsa, Chair. At this time all participants will be in a listen-only mode. [...]

Published
2024

46. Codexis Inc Annual Shareholders Meeting - Final

Subjects
Codexis Inc. -- Officials and employees, Biological products industry -- Officials and employees, Stockholders, Business
Abstract

Presentation STEPHEN DILLY, PRESIDENT, CHIEF EXECUTIVE OFFICER, DIRECTOR, CODEXIS INC: Good morning. My name is Stephen Dilly, and I'm President and Chief Executive Officer of Codexis, Inc. I'm very happy [...]

Published
2024

47. Sutro Biopharma Inc Annual Shareholders Meeting - Final

Subjects
Ernst & Young L.L.P. -- Officials and employees, Biological products industry -- Officials and employees, Chief financial officers, Accounting firms -- Officials and employees, Stockholders, Business
Abstract

Presentation WILLIAM NEWELL, CHIEF EXECUTIVE OFFICER, DIRECTOR, SUTRO BIOPHARMA INC: Good morning, ladies and gentlemen, I am Will Newell, CEO of Sutro Biopharma. It's a pleasure to welcome you to [...]

Published
2024

48. Cerus Corp Annual Shareholders Meeting - Final

Subjects
Cerus Corp. -- Officials and employees, Biological products industry -- Officials and employees, Stockholders, Business
Abstract

Presentation OPERATOR: Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Cerus Corporation 2024 Annual Stockholders Meeting. Please be advised that today's meeting is being [...]

Published
2024

49. Achieve Life Sciences Inc Annual Shareholders Meeting - Final

Subjects
Life Sciences Inc. -- Officials and employees, Biological products industry -- Officials and employees, Web portals, Insurance industry -- Officials and employees, Chairpersons, Stockholders, Insurance industry, Web portal, Business
Abstract

Presentation OPERATOR: Good morning, and welcome to the Annual Meeting for Achieve Life Sciences, Inc. Our host for today's call is John Bencich, CEO. (Operator Instructions) I will now turn [...]

Published
2024

50. Cerus Corp Annual Shareholders Meeting - Final

Subjects
Cerus Corp. -- Officials and employees, Biological products industry -- Officials and employees, Stockholders, Business
Abstract

Presentation OPERATOR: Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Cerus Corporation 2024 Annual Stockholders Meeting. Please be advised that today's meeting is being [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results